Contact Lenses/Eye Wear News

Johnson & Johnson Vision announced the launch of Acuvue Oasys Multifocal with Pupil Optimized Design for patients with presbyopia.

CooperVision has partnered with the American Academy of Ophthalmology and the World Council of Optometry to address worldwide myopia and promote a standard of care for the disease, the company announced in recent press releases.

MediPrint Ophthalmic announced that the SIGHT-1 clinical trial found a favorable safety and tolerability profile and demonstrated single dose efficacy of the LLT-BMT1 drug-eluting contact lens to treat mild to moderate glaucoma or ocular hypertension.

The Japanese Ministry of Health, Labour and Welfare approved Johnson & Johnson Vision’s Acuvue Theravision with Ketotifen, a drug-releasing combination contact lens designed for both vision correction and allergic eye itch relief.

A 6-year clinical trial of 114 children between the ages of 8 and 12 years confirmed the safety of daily disposable hydrogel contact lenses and identified slowed progression of myopia in children who wore CooperVision’s MiSight lenses.

Razer, a lifestyle brand for gamers, announced it has entered the eye wear and wearable technology industry with a new product geared toward remote working.

Results from the Vision Council’s 2021 Eyecare Provider Insights Survey show high capture rates despite low numbers of eye exams, with 55% of providers reporting capture rates being normal or better than typical January results.

Visionary Optics has launched its new product line, VibrantVue, a high-quality cost-effective eye care line for practitioners and patients, according to a press release.

The comfort scores calculated for three types of toric contact lenses correlated with subjective vision quality and lens type, according to study results published in Contact Lens and Anterior Eye.

CooperCompanies and EssilorLuxottica announced a partnership to accelerate commercialization of SightGlass Vision spectacle lenses, which are designed to slow the progression of myopia in children, according to press releases from the companies.